Showing 1 - 6 results of 6 for search 'López-Saura Pedro', query time: 0.03s Refine Results
  1. 1
    Treatment of advanced, recurrent, resistant to previous treatments basal and squamous cell skin carcinomas with a synergistic formulation of interferons. Open, prospective study

    Treatment of advanced, recurrent, resistant to previous treatments basal and squamous cell skin carcinomas with a synergistic formulation of interferons. Open, prospective study by Lopez-Saura Pedro, Barcelona-Perez Silvia, Garcia-Vega Yanelda, Anasagasti-Angulo Lorenzo, Bello-Rivero Iraldo

    Published 2009-07-01
    Get full text
    Article
  2. 2
    Construction, purification, and characterization of a chimeric TH1 antagonist

    Construction, purification, and characterization of a chimeric TH1 antagonist by Javier-González Luís, Fernández-Batista Osmani, Pentón-Rol Giselle, Blanco-Garcés Elizabeth, Torrez-Ruiz Yeny, Bello-Rivero Iraldo, Gerónimo-Perez Haydee, López-Saura Pedro

    Published 2006-05-01
    Get full text
    Article
  3. 3
    Adjuvant interferon gamma in patients with drug – resistant pulmonary tuberculosis: a pilot study

    Adjuvant interferon gamma in patients with drug – resistant pulmonary tuberculosis: a pilot study by Carbonell Dalia, Milanés-Virelles María T, Valdés-Quintana Magalys, Fernández-Olivera Norma, García-García Idrian, Suárez-Méndez Roberto, Machado-Molina Delfina, Valenzuela-Silva Carmen M, López-Saura Pedro A

    Published 2004-10-01
    Get full text
    Article
  4. 4
    TNF-<it>α </it>and IL-10 downregulation and marked oxidative stress in Neuromyelitis Optica

    TNF-<it>α </it>and IL-10 downregulation and marked oxidative stress in Neuromyelitis Optica by Casanova-Orta Mayté, Ramírez-Nuñez Omar, Valenzuela-Silva Carmen M, Cabrera-Gómez José A, Martínez-Sánchez Gregorio, Cervantes-Llanos Majel, Pentón-Rol Giselle, Robinson-Agramonte María A, Lopategui-Cabezas Ileana, López-Saura Pedro A

    Published 2009-06-01
    Get full text
    Article
  5. 5
    Safety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies

    Safety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies by Alonso Daniel F, Gómez Roberto, Ramos Thelvia, Castillo Dagnelia, Díaz Alina, González Carlos A, Valenzuela Carmen, Baladrón Idania, Santana Agueda, Solares Ana M, Herrera Luis, Sigman Hugo, Perea Silvio E, Acevedo Boris E, López-Saura Pedro

    Published 2009-05-01
    Get full text
    Article
  6. 6
    Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: A randomized, double-blind, placebo-controlled study

    Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: A randomized, double-blind, placebo-controlled study by Sánchez-de la Osa Reinaldo B, Fernández-Olivera Norma, Bello-Rivero Iraldo, Ramos-Gómez Thelvia I, Jiménez-Madrigal Gaspar, Valenzuela-Silva Carmen M, Valdés-Quintana Magalys, Santos-Herrera Yamilet, García-García Idrian, Milanés-Virelles María T, Rodríguez-Acosta Carmen, González-Méndez Lidia, Martínez-Sánchez Gregorio, López-Saura Pedro A

    Published 2008-02-01
    Get full text
    Article

Search Tools: